Comparison of Balloon Angioplasty and Stent Implantation for Femoropopliteal Disease According to Patient and Lesion Subgroup-Reference-Cited by-同舟云学术

Comparison of Balloon Angioplasty and Stent Implantation for Femoropopliteal Disease According to Patient and Lesion Subgroup

Published:2019-02-08 Issue:2 Volume:1 Page:94-101
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Kobayashi Norihiro¹,Hirano Keisuke¹,Yamawaki Masahiro¹,Araki Motoharu¹,Sakai Tsuyoshi¹,Obokata Masaru²,Sakamoto Yasunari¹,Mori Shinsuke¹,Tsutsumi Masakazu¹,Nauchi Masahiro¹,Honda Yohsuke¹,Makino Kenji¹,Shirai Shigemitsu¹,Sugizaki Yuta¹,Fukagawa Tomoya¹,Kishida Toshihiko¹,Ito Yoshiaki¹

Affiliation:

1. Department of Cardiology, Saiseikai Yokohama City Eastern Hospital

2. Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/1/2/1_CR-18-0028/_pdf

Reference29 articles.

1. 1. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879–1888.

2. 2. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009; 74: 1090–1095.

3. 3. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation 2016; 133: 1472–1483; discussion 1483.

4. 4. Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y, et al. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): A randomised, non-inferiority trial. Lancet 2018; 392: 1541–1551.

5. 5. Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, et al. Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: Long-term results of the IN.PACT SFA randomized trial. Circ Cardiovasc Interv 2018; 11: e005891.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three-Year Clinical Outcomes Following Implantation of LifeStent Self-Expanding Nitinol Stents in Patients With Femoropopliteal Artery Lesions;Angiology;2021-09-08